Cite
HARVARD Citation
Attard, G. et al. (n.d.). 2537 Preliminary findings from PLATO: A two-period, phase 4, randomized, double-blind, placebo-controlled study of continued enzalutamide treatment beyond progression in men with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC). European journal of cancer. pp. S487-. [Online].